Dosimetric assessment of static and helical TomoTherapy in the clinical implementation of breast cancer treatments

The TomoTherapy and TomoDirect modalities can deliver dose distributions which the radiotherapist judges to be equal to or better than conventional treatment of breast carcinoma according to the organ to be protected.